Home » Topics » BioWorld Science

BioWorld Science
RSS

Cullgen identifies new PROTACs

April 27, 2022

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

April 27, 2022

LYL-797, ROR1-targeted CAR T-cell candidate designed using reprogramming technologies

April 27, 2022

RaQualia Pharma patents CRF2 receptor antagonists

April 27, 2022

Metacrine divulges new HSD17B13 inhibitors

April 27, 2022

ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models

April 27, 2022

QL-401 shows improved blood safety and is efficacious against solid and hematologic cancers

April 27, 2022

NBL-028: a CLDN6-CD137 bispecific antibody for treating CLDN6-positive tumors

April 27, 2022

Researchers develop gene-editing platform to edit mitochondrial DNA

April 26, 2022

PAK4 inhibition enhances anti-PD-1 therapy in prostate cancer

April 26, 2022

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...